Stay updated with breaking news from Segments Profiled. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global Head and Neck Cancer (HNC) Therapeutics market is anticipated to surpass a remarkable worth of US$ 1.58 Billion in 2023, with a compound annual growth rate (CAGR) of 12.6% from 2023 to 2033. Developments in the detection and treatment of head and neck cancer (HNC) are expected to propel market expansion a...
A recently published study by FMI expects the global common warts market to augment at a 3.6% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 1,100 Million is expected for the market. The increase in pharmaceutical R&D activity for efficient and focused treatment of common warts...
[Report of 250 Pages] In 2032, the market for neuro monitoring systems is expected to be worth US$9.4 billion. The market for neuro monitoring systems is expected to grow in the coming years due to the rising number of complicated and critical surgeries performed around the world. The demand for neuro monitoring sys...
The global malignant pleural effusion market is expected to garner a market value of US$ 4.5 Billion in 2023 and is expected to accumulate a market value of US$ 8.06 Billion by registering a CAGR of 6% in the forecast period 2023-2033. The increasing incidence of pleural effusion disease and rising awareness of adva...
NAATs Expected to Hold 49% Of Market Share for Chlamydia diagnostics Market. The Chlamydia Diagnostics Market refers to the market for tests and assays...